Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The general enzyme targets of quercetin and kaempferol represent a diverse group of proteins involved in critical cellular processes such as signal transduction, inflammation, and oxidative stress management (PMID: 27027332). These flavonoids are recognized for their ability to interact with and inhibit several key enzymes, most notably phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinases (MAPK), and various protein tyrosine kinases (PMID: 30746536). Beyond kinases, they also target enzymes like cyclooxygenase (COX-1 and COX-2) and lipoxygenase (LOX), which are central to the inflammatory response, as well as xanthine oxidase and topoisomerases (PMID: 18417135). By modulating these enzymatic activities, quercetin and kaempferol exhibit significant anti-cancer, anti-inflammatory, and cardioprotective properties in preclinical models (PubChem CID 5280343). However, their therapeutic application is complicated by low systemic bioavailability and the potential for drug-drug interactions due to their inhibitory effects on metabolic enzymes like Cytochrome P450 3A4 (CYP3A4) (PMID: 23673480). Their interaction typically involves competitive inhibition at the ATP-binding site of kinases or the active sites of metabolic enzymes, leading to altered signaling pathways and reduced production of inflammatory mediators.
Quercetin and kaempferol primarily act as competitive inhibitors of ATP binding in various protein kinases, such as phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinases (MAPK) (PMID: 27027332). They also inhibit the activity of enzymes involved in the arachidonic acid cascade, including cyclooxygenase (COX) and lipoxygenase (LOX), thereby reducing the production of pro-inflammatory eicosanoids (PMID: 30746536). Additionally, they can modulate the activity of phase II detoxifying enzymes and antioxidant enzymes like xanthine oxidase (PMID: 18417135).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General enzyme targets of quercetin and kaempferol.